Actualités

When Rite Aid, a major pharmacy retailer, filed for Chapter 11 bankruptcy a second time in 2025, it led to the shuttering of its 1,250 locations. Over time, many were sold to competitors like CVS and Walgreens, and some spaces were taken up by retailers such as Kroger and Albertsons. But some ...

Healthcare has spent 2026 on the sidelines while the rest of the market does the heavy lifting. The Health Care Select Sector SPDR Fund (NYSEARCA:XLV) is down around 1% year to date even after a 6% one-month bounce. That stagnation has left a handful of high-margin operators trading at forward multiples that look out of ... 3 Ridiculously Cheap Healthcare Stocks to Buy in June

Molina Healthcare secures an Illinois Medicaid managed care contract starting in 2027, reinforcing its position in a key market and supporting long-term growth.

Here’s a 30,000-foot view on practical ways to protect your investing capital and gain a real edge over the house in a stock market designed to keep you glued to the slots instead of growing your wealth.

The tentative deal comes months after CVS Health reached a proposed settlement in the lawsuit alleging major pharmacy benefit managers are inflating insulin costs.

Over the past six months, CVS Health has been a great trade, beating the S&P 500 by 20%. Its stock price has climbed to $100.39, representing a healthy 26.4% increase. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.

In recent days, CVS Health expanded access to GLP-1 weight management drugs, reintroducing Zepbound and easing restrictions on new oral therapies, while also advancing AI-driven tools across its pharmacy, insurance and care delivery platforms. Together, these moves highlight how CVS is trying to pair broader drug affordability with technology-led efficiencies in care delivery and operations. Next, we’ll examine how CVS’s broader GLP-1 coverage and affordability push could influence the...

DHR closes its $9.9B Masimo acquisition, adding AI-enabled patient-monitoring and sensor technologies to expand diagnostics solutions.

STNE, USNA, STRA, NEXA and CVS passed a low price-to-book screen, combining discounted valuations with projected long-term EPS growth.

CVS Health (CVS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Federal investigators raised concerns about how Medicare Advantage plans handle requests for post-hospital recovery care, finding that many denials were later overturned on appeal. Two reports from the Office of Inspector General at the Department of Health and Human Services...

Danaher is seeing strong Biotechnology growth as bioprocessing demand rises, with equipment orders up more than 30% and core revenue gains expected in 2026.

After four years as chief merchandising officer, Balbale has departed CVS.

Economist Justin Wolfers dropped a number on the Prof G Markets podcast that should reorganize how you think about the 2026 economy. Since Trump took office, healthcare and social services has added roughly 901,000 jobs, while every other part of the economy has actually lost jobs on net. One sector hiring. Everything else shedding. Before ... Trump’s Economy Hired Nearly 1 Million Healthcare Workers While Every Other Sector Lost Jobs. Here’s Where to Put Your Money

CVS Health (CVS) has moved to expand access to GLP-1 weight management drugs by reintroducing Zepbound and easing access to new oral therapy Foundayo, as regulators and courts scrutinize its pharmacy benefit practices. See our latest analysis for CVS Health. The recent formulary decisions on GLP 1 weight management drugs, along with Aetna’s new mental health services and expanded AI enabled call center partnership, have coincided with a 90 day share price return of 27.2% and a 1 year total...

The state said it intends to divvy out new contracts, which represent tens of billions of dollars in revenue for each awardee, to six insurers. Winners are mostly incumbents, except for Humana.

CVS Health Corporation (NYSE:CVS) is one of the Best Blue Chip Stocks Under $100 to Buy Now. On June 1, Truist lifted its price objective on the company’s stock to $108 from $102 and maintained a “Buy” rating on the shares. This forms part of the research note on the broader managed healthcare companies. The analyst […]

Here is how CVS Health (CVS) and Align Technology (ALGN) have performed compared to their sector so far this year.

The Dow’s industrial-era anchors are quietly outpacing the broader market. Over the past year, the SPDR S&P 500 ETF Trust (NYSEARCA: SPY) returned 24.37%, and the Dow tracker returned 20.22%. Three “old economy” Dow components have left both benchmarks in the dust, and they share more than just a ticker on the same index. What ... These 3 ‘Old Economy’ Dow Stocks Are Quietly Crushing the Market, and Here’s What They All Share

CVS Health (NYSE:CVS) is facing lawsuits from multiple health systems that allege the company diverted hundreds of millions of dollars in savings tied to the federal 340B drug discount program. At the same time, CVS Health is expanding access to GLP-1 weight management drugs through new formulary decisions, including the reintroduction of Zepbound and removal of barriers for Foundayo. These developments come as pharmacy benefit manager practices receive increased attention from regulators...

The latest trading day saw CVS Health (CVS) settling at $95.93, representing a +1.17% change from its previous close.

After a brutal stretch, the insurance behemoth came roaring back. But does the underlying data fully support the sustainability of this momentum.

CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

It's another step in Eli Lilly's quest to cement its lead in the chronic weight management market.

Dow Jones futures fell slightly after hours, along with S&P 500 futures and Nasdaq futures. The May jobs report is on tap before Friday's open. The stock market saw the Dow Jones jump to a record high, aided by lower oil prices and Treasury yields.

The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.41%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +1.73%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.53%. June E-mini S&P futures (ESM26 ) rose +0.36%, and June E-mini Nasdaq futures...

Health insurers are running higher in Thursday afternoon trading after a wave of bullish Wall Street analyst notes on the managed-care sector, centered on UnitedHealth, citing softer medical cost and utilization trends plus potential AI efficiency upside. Humana (NYSE:HUM) stock is leading the move, up 6% to $348, with UnitedHealth Group (NYSE:UNH) stock up 5% ... Humana Jumps 6%, UnitedHealth Climbs 5%, Cigna Rises 4% as Analysts Cheer Softer Medical Cost Trends

Shares of UnitedHealth Group receive votes of confidence from analysts at BofA Securities and Morgan Stanley.

CVS Health (CVS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).